Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Novuson Surgical Inc. See All Filings	C/A	2022-04-28 14:24:14 UTC
Financial Interest We charge 2% commission paid in equity or securities at the same rate as this offering. Filing Platform StartEngine Capital, LLC Offering Amount $1,070,000 CIK Number 0001655934 Filed Document 0001665160-22-001099 Accepted Date 2022-04-28 14:24:14 UTC Type of Offering C/A Security Offered Amount 15,625 Security Offered Type Common Stock State WASHINGTON
Novuson Surgical Inc. See All Filings	C/A	2022-04-13 17:22:46 UTC
Financial Interest We charge 2% commission paid in equity or securities at the same rate as this offering. Filing Platform StartEngine Capital, LLC Offering Amount $1,070,000 CIK Number 0001655934 Filed Document 0001665160-22-000647 Accepted Date 2022-04-13 17:22:46 UTC Type of Offering C/A Security Offered Amount 15,625 Security Offered Type Common Stock State WASHINGTON
Novuson Surgical Inc. See All Filings	C	2022-03-25 15:24:11 UTC
Financial Interest Two percent (2%) of securities of the total amount of investments raised in the offering, along the same terms as investors. Filing Platform StartEngine Capital, LLC Offering Amount $1,070,000 CIK Number 0001655934 Filed Document 0001665160-22-000534 Accepted Date 2022-03-25 15:24:11 UTC Type of Offering C Security Offered Amount 15,625 Security Offered Type Common Stock State WASHINGTON
Novuson Surgical, Inc. See All Filings	D	2020-03-31 13:43:29 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001655934 Filed Document 0001591408-20-000006 Exclusions or Exemptions 506b Accepted Date 2020-03-31 13:43:29 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Novuson Surgical, Inc. See All Filings	D	2015-10-16 00:00:00 UTC
Amount To Be Raised $5,840,000 Associated Brokers / Dealers Novuson Surgical, Inc. CIK Number 0001655934 Filed Document 0001655934-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-10-16 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets $No Revenues Type of Security Equity